cabazitaxel accord
accord healthcare s.l.u. - kabazitaxel - prosztata daganatok, kasztráció-rezisztens - daganatellenes szerek - treatment of patients with hormone refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen.
abiraterone accord
accord healthcare s.l.u. - abirateron-acetát - prosztatikus daganatok - endokrin terápia - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone mylan
mylan ireland limited - abirateron-acetát - prosztatikus daganatok - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone krka
krka, d.d., novo mesto - abirateron-acetát - prosztatikus daganatok - endokrin terápia - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
herwenda
sandoz gmbh - trastuzumab - breast neoplasms; stomach neoplasms - daganatellenes szerek - treatment of metastatic and early breast cancer and metastatic gastric cancer (mgc).
pemetrexed sun 100 mg por oldatos infúzióhoz való koncentrátumhoz
sun pharmaceutical industries europe b.v. - pemetrexed -
pemetrexed sun 500 mg por oldatos infúzióhoz való koncentrátumhoz
sun pharmaceutical industries europe b.v. - pemetrexed -
pemetrexed sun 1000 mg por oldatos infúzióhoz való koncentrátumhoz
sun pharmaceutical industries europe b.v. - pemetrexed -
pemetrexed ever pharma 25 mg/ml koncentrátum oldatos infúzióhoz
ever valinject gmbh - pemetrexed -
cabazitaxel teva 10 mg/ml koncentrátum oldatos infúzióhoz
teva b.v. - cabazitaxel -